Sanchez Ramiro 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Dec 28, 2023
Insider Transaction Report
Form 4
Sanchez Ramiro
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-26$3.50/sh+10,000$35,000→ 24,673 total - Sale
Common Stock
2023-12-26$42.47/sh−10,000$424,700→ 14,673 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-26−10,000→ 538,435 totalExercise: $3.50Exp: 2029-02-27→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 4, 2023 adopted by the Reporting Person.
- [F2]The option is fully vested and exercisable.